Temat: "Anti-Arrhythmia Agents" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Freedom from atrial arrhythmia and other clinical outcomes at 5 years and beyond after catheter ablation of atrial fibrillation: a systematic review and meta-analysis.
Autorzy:: Ngo L; Greater Brisbane Clinical School, Medical School, The University of Queensland, Chermside, QLD 4032, Australia.; Department of Cardiology, The Prince Charles Hospital, Chermside, QLD 4032, Australia.
Lee XW; Greater Brisbane Clinical School, Medical School, The University of Queensland, Chermside, QLD 4032, Australia.; Department of Cardiology, The Prince Charles Hospital, Chermside, QLD 4032, Australia.
Elwashahy M; The Wollongong Hospital, Wollongong, NSW 2500, Australia.
Arumugam P; Greater Brisbane Clinical School, Medical School, The University of Queensland, Chermside, QLD 4032, Australia.
Yang IA; Greater Brisbane Clinical School, Medical School, The University of Queensland, Chermside, QLD 4032, Australia.; Department of Thoracic Medicine, The Prince Charles Hospital, Chermside, QLD 4032, Australia.
Denman R; Department of Cardiology, The Prince Charles Hospital, Chermside, QLD 4032, Australia.
Haqqani H; Greater Brisbane Clinical School, Medical School, The University of Queensland, Chermside, QLD 4032, Australia.; Department of Cardiology, The Prince Charles Hospital, Chermside, QLD 4032, Australia.
Ranasinghe I; Greater Brisbane Clinical School, Medical School, The University of Queensland, Chermside, QLD 4032, Australia.; Department of Cardiology, The Prince Charles Hospital, Chermside, QLD 4032, Australia.; Pokaż więcej
Źródło:: European heart journal. Quality of care & clinical outcomes [Eur Heart J Qual Care Clin Outcomes] 2023 Aug 07; Vol. 9 (5), pp. 447-458.
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:: Atrial Fibrillation*/drug therapy
Stroke*/complications
Catheter Ablation*/adverse effects
Catheter Ablation*/methods
Humans ; Male ; Middle Aged ; Female ; Treatment Outcome ; Anti-Arrhythmia Agents/therapeutic use ; Hemorrhage

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Sequential hybrid ablation versus surgical CryoMaze alone for treatment of atrial fibrillation (SurHyb Trial): a protocol of the multicentre randomized controlled trial.
Autorzy:: Bulava A; University of South Bohemia in Ceske Budejovice, Faculty of Health and Social Sciences; Cardiac Centre, Ceske Budejovice Hospital, Ceske Budejovice, Czech Republic.
Mokracek A; University of South Bohemia in Ceske Budejovice, Faculty of Health and Social Sciences; Cardiac Centre, Ceske Budejovice Hospital, Ceske Budejovice, Czech Republic.
Wichterle D; Institute for Clinical and Experimental Medicine, Praha, Czech Republic.
Budera P; Institute for Clinical and Experimental Medicine, Praha, Czech Republic.
Osmancik P; Charles University and University Hospital Kralovske Vinohrady, 3rd Faculty of Medicine, Praha, Czech Republic.
Kacer P; Charles University and University Hospital Kralovske Vinohrady, 3rd Faculty of Medicine, Praha, Czech Republic.
Veteskova L; Centre of Cardiovascular Surgery and Transplantation, Brno, Czech Republic.
Nemec P; Centre of Cardiovascular Surgery and Transplantation, Brno, Czech Republic.
Skala T; Palacky University, Faculty of Medicine and Dentistry; University Hospital Olomouc, Olomouc, Czech Republic.
Santavy P; Palacky University, Faculty of Medicine and Dentistry; University Hospital Olomouc, Olomouc, Czech Republic.
Chovancik J; Hospital Agel Trinec-Podlesi, Trinec, Czech Republic.
Branny P; Hospital Agel Trinec-Podlesi, Trinec, Czech Republic.
Rizov V; Masaryk Hospital, Usti nad Labem, Czech Republic.
Kolesar M; Masaryk Hospital, Usti nad Labem, Czech Republic.
Rybar M; Czech Technical University in Prague, Faculty of Biomedical Engineering, Department of Biomedical Technology, Kladno, Czech Republic.; Pokaż więcej
Źródło:: Journal of applied biomedicine [J Appl Biomed] 2023 Jun; Vol. 21 (2), pp. 67-72. Date of Electronic Publication: 2023 May 11.
Typ publikacji:: Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Atrial Fibrillation*/surgery
Atrial Fibrillation*/drug therapy
Cardiac Surgical Procedures*/methods
Catheter Ablation*/methods
Humans ; Anti-Arrhythmia Agents/therapeutic use ; Multicenter Studies as Topic ; Prospective Studies ; Randomized Controlled Trials as Topic ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Mid term freedom from atrial fibrillation following hybrid ablation, a systematic review and meta analysis.
Autorzy:: Eranki A; Department of Cardiothoracic Surgery, St. George Hospital, Kograh, Sydney, 2217, Australia. .
Wilson-Smith A; The Chris O'Brien Lifehouse Center, Sydney, Australia.; The Collaborative Research Group (CORE), Sydney, Australia.; The University of Sydney, Sydney, Australia.; The John Hunter Hospital, Newcastle, Australia.
Flynn C; Department of Cardiothoracic Surgery, St. George Hospital, Kograh, Sydney, 2217, Australia.
Williams M; Department of Cardiothoracic Surgery, Dunedin Hospital, Great King Street, Dunedin Otago, New Zealand.
Manganas C; Department of Cardiothoracic Surgery, St. George Hospital, Kograh, Sydney, 2217, Australia.; Pokaż więcej
Źródło:: Journal of cardiothoracic surgery [J Cardiothorac Surg] 2023 Apr 19; Vol. 18 (1), pp. 155. Date of Electronic Publication: 2023 Apr 19.
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:: Atrial Fibrillation*/surgery
Catheter Ablation*/adverse effects
Catheter Ablation*/methods
Humans ; Treatment Outcome ; Anti-Arrhythmia Agents ; Heart ; Recurrence ; Randomized Controlled Trials as Topic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Relationship between amiodarone response prior to ablation and 1-year outcomes of catheter ablation for atrial fibrillation.
Autorzy:: Yadav R; Division of Cardiology, Johns Hopkins Medicine, Baltimore, Maryland, USA.
Brilliant J; Division of Cardiology, Johns Hopkins Medicine, Baltimore, Maryland, USA.
Akhtar T; Division of Cardiology, Johns Hopkins Medicine, Baltimore, Maryland, USA.
Milstein J; Division of Cardiology, Johns Hopkins Medicine, Baltimore, Maryland, USA.
Sampognaro JR; Division of Cardiology, Johns Hopkins Medicine, Baltimore, Maryland, USA.
Marine J; Division of Cardiology, Johns Hopkins Medicine, Baltimore, Maryland, USA.
Berger R; Division of Cardiology, Johns Hopkins Medicine, Baltimore, Maryland, USA.
Calkins H; Division of Cardiology, Johns Hopkins Medicine, Baltimore, Maryland, USA.
Spragg D; Division of Cardiology, Johns Hopkins Medicine, Baltimore, Maryland, USA.; Pokaż więcej
Źródło:: Journal of cardiovascular electrophysiology [J Cardiovasc Electrophysiol] 2023 Apr; Vol. 34 (4), pp. 860-868. Date of Electronic Publication: 2023 Feb 22.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Amiodarone*/therapeutic use
Atrial Fibrillation*/surgery
Ablation Techniques*
Catheter Ablation*/adverse effects
Humans ; Anti-Arrhythmia Agents/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Temporal trends in atrial fibrillation ablation procedures at an academic medical center: 2011-2021.
Autorzy:: Kushnir A; Leon H. Charney Division of Cardiology, Cardiac Electrophysiology, NYU Langone Health, New York University Grossman School of Medicine, New York, USA.
Barbhaiya CR; Leon H. Charney Division of Cardiology, Cardiac Electrophysiology, NYU Langone Health, New York University Grossman School of Medicine, New York, USA.
Aizer A; Leon H. Charney Division of Cardiology, Cardiac Electrophysiology, NYU Langone Health, New York University Grossman School of Medicine, New York, USA.
Jankelson L; Leon H. Charney Division of Cardiology, Cardiac Electrophysiology, NYU Langone Health, New York University Grossman School of Medicine, New York, USA.
Holmes D; Leon H. Charney Division of Cardiology, Cardiac Electrophysiology, NYU Langone Health, New York University Grossman School of Medicine, New York, USA.
Knotts R; Leon H. Charney Division of Cardiology, Cardiac Electrophysiology, NYU Langone Health, New York University Grossman School of Medicine, New York, USA.
Park D; Leon H. Charney Division of Cardiology, Cardiac Electrophysiology, NYU Langone Health, New York University Grossman School of Medicine, New York, USA.
Spinelli M; Leon H. Charney Division of Cardiology, Cardiac Electrophysiology, NYU Langone Health, New York University Grossman School of Medicine, New York, USA.
Bernstein S; Leon H. Charney Division of Cardiology, Cardiac Electrophysiology, NYU Langone Health, New York University Grossman School of Medicine, New York, USA.
Chinitz LA; Leon H. Charney Division of Cardiology, Cardiac Electrophysiology, NYU Langone Health, New York University Grossman School of Medicine, New York, USA.; Pokaż więcej
Źródło:: Journal of cardiovascular electrophysiology [J Cardiovasc Electrophysiol] 2023 Apr; Vol. 34 (4), pp. 800-807. Date of Electronic Publication: 2023 Feb 14.
Typ publikacji:: Journal Article
MeSH Terms:: Atrial Fibrillation*/surgery
Catheter Ablation*/methods
Humans ; Treatment Outcome ; Anti-Arrhythmia Agents/therapeutic use ; Time Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Mortality benefit of catheter ablation versus medical therapy in atrial fibrillation: An RCT only meta-analysis.
Autorzy:: Ravi V; Division of Cardiology, Department of Medicine, Section of Electrophysiology, Rush University Medical Center, Chicago, USA.; Department of Cardiovascular Science, Warren Clinic Cardiology, Saint Francis Heart Hospital, Tulsa, USA.
Poudyal A; Department of Medicine, John H Stroger Hospital of Cook County, Chicago, USA.
Lin L; Department of Medicine, John H Stroger Hospital of Cook County, Chicago, USA.
Larsen T; Division of Cardiology, Department of Medicine, Section of Electrophysiology, Rush University Medical Center, Chicago, USA.
Wasserlauf J; Division of Cardiology, Department of Medicine, Section of Electrophysiology, Rush University Medical Center, Chicago, USA.
Trohman RG; Division of Cardiology, Department of Medicine, Section of Electrophysiology, Rush University Medical Center, Chicago, USA.
Krishnan K; Division of Cardiology, Department of Medicine, Midwest Cardiovascular Institute, Naperville, USA.
Sharma P; Division of Cardiology, Department of Medicine, Section of Electrophysiology, Rush University Medical Center, Chicago, USA.
Huang HD; Division of Cardiology, Department of Medicine, Section of Electrophysiology, Rush University Medical Center, Chicago, USA.; Pokaż więcej
Źródło:: Journal of cardiovascular electrophysiology [J Cardiovasc Electrophysiol] 2022 Feb; Vol. 33 (2), pp. 178-193. Date of Electronic Publication: 2021 Dec 21.
Typ publikacji:: Journal Article; Meta-Analysis
MeSH Terms:: Anti-Arrhythmia Agents*/therapeutic use
Atrial Fibrillation*/drug therapy
Atrial Fibrillation*/mortality
Atrial Fibrillation*/surgery
Catheter Ablation*
Adult ; Humans ; Randomized Controlled Trials as Topic ; Stroke Volume ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Long-term outcomes following catheter ablation versus medical therapy in patients with persistent atrial fibrillation and heart failure with reduced ejection fraction.
Autorzy:: Zakeri R; British Heart Foundation Centre for Research Excellence, Faculty of Life Sciences and Medicine, King's College London, London, UK.; Royal Brompton and Harefield Hospitals, Guys and St Thomas' NHS Foundation Trust, London, UK.
Ahluwalia N; National Heart and Lung Institute, Imperial College London, London, UK.
Tindale A; Royal Brompton and Harefield Hospitals, Guys and St Thomas' NHS Foundation Trust, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK.
Omar F; Royal Brompton and Harefield Hospitals, Guys and St Thomas' NHS Foundation Trust, London, UK.
Packer M; Royal Brompton and Harefield Hospitals, Guys and St Thomas' NHS Foundation Trust, London, UK.
Khan H; Royal Brompton and Harefield Hospitals, Guys and St Thomas' NHS Foundation Trust, London, UK.
Baker V; St Bartholomew's Heart Centre, London, UK.
Honarbakhsh S; St Bartholomew's Heart Centre, London, UK.
Earley MJ; St Bartholomew's Heart Centre, London, UK.
Sporton S; St Bartholomew's Heart Centre, London, UK.
Schilling RJ; St Bartholomew's Heart Centre, London, UK.
Jones D; Royal Brompton and Harefield Hospitals, Guys and St Thomas' NHS Foundation Trust, London, UK.
Markides V; Royal Brompton and Harefield Hospitals, Guys and St Thomas' NHS Foundation Trust, London, UK.
Hunter RJ; St Bartholomew's Heart Centre, London, UK.
Wong T; British Heart Foundation Centre for Research Excellence, Faculty of Life Sciences and Medicine, King's College London, London, UK.; Royal Brompton and Harefield Hospitals, Guys and St Thomas' NHS Foundation Trust, London, UK.; Pokaż więcej
Corporate Authors:: ARC-HF and CAMTAF Investigators
Źródło:: European journal of heart failure [Eur J Heart Fail] 2023 Jan; Vol. 25 (1), pp. 77-86. Date of Electronic Publication: 2022 Nov 01.
Typ publikacji:: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Atrial Fibrillation*/complications
Atrial Fibrillation*/surgery
Heart Failure*
Ventricular Dysfunction, Left*/drug therapy
Catheter Ablation*/methods
Humans ; Middle Aged ; Aged ; Stroke Volume ; Ventricular Function, Left ; Treatment Outcome ; Anti-Arrhythmia Agents/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Impact of redo ablation for atrial fibrillation on patient-reported outcomes and quality of life.
Autorzy:: Farwati M; Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
Amin M; Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
Saliba WI; Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Nakagawa H; Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Tarakji KG; Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Diab M; Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Scandinaro A; Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
Madden R; Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Bouscher P; Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Kuroda S; Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Kanj M; Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Dresing TJ; Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Callahan TD; Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Bhargava M; Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Sroubek J; Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Baranowski B; Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Rickard J; Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Cantillon DJ; Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Tchou PJ; Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Wazni OM; Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Hussein AA; Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA.; Pokaż więcej
Źródło:: Journal of cardiovascular electrophysiology [J Cardiovasc Electrophysiol] 2023 Jan; Vol. 34 (1), pp. 54-61. Date of Electronic Publication: 2022 Nov 02.
Typ publikacji:: Journal Article
MeSH Terms:: Atrial Fibrillation*/diagnosis
Atrial Fibrillation*/surgery
Catheter Ablation*/adverse effects
Female ; Humans ; Middle Aged ; Male ; Quality of Life ; Treatment Outcome ; Anti-Arrhythmia Agents/therapeutic use ; Patient Reported Outcome Measures

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: The Future of Antiarrhythmic Drug Therapy: Will Drugs Be Entirely Replaced by Procedures?
Autorzy:: Valderrábano M; Houston Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, Houston, Texas, US.; Pokaż więcej
Źródło:: Methodist DeBakey cardiovascular journal [Methodist Debakey Cardiovasc J] 2022 Dec 06; Vol. 18 (5), pp. 58-63. Date of Electronic Publication: 2022 Dec 06 (Print Publication: 2022).
Typ publikacji:: Journal Article; Review
MeSH Terms:: Atrial Fibrillation*/diagnosis
Atrial Fibrillation*/drug therapy
Atrial Fibrillation*/surgery
Tachycardia, Ventricular*/diagnosis
Tachycardia, Ventricular*/drug therapy
Tachycardia, Ventricular*/surgery
Catheter Ablation*/adverse effects
Humans ; Anti-Arrhythmia Agents/adverse effects ; Sotalol/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Improved survival in patients with atrial fibrillation and heart failure undergoing catheter ablation compared to medical treatment: A systematic review and meta-analysis of randomized controlled trials.
Autorzy:: Romero J; Department of Medicine, Cardiac Arrhythmia Center, Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Division of Cardiology, Albert Einstein College of Medicine, Bronx, New York, USA.
Gabr M; Department of Medicine, Cardiac Arrhythmia Center, Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Division of Cardiology, Albert Einstein College of Medicine, Bronx, New York, USA.
Alviz I; Department of Medicine, Cardiac Arrhythmia Center, Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Division of Cardiology, Albert Einstein College of Medicine, Bronx, New York, USA.
Briceno D; Department of Medicine, Cardiac Arrhythmia Center, Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Division of Cardiology, Albert Einstein College of Medicine, Bronx, New York, USA.
Diaz JC; Department of Medicine, Cardiac Arrhythmia Center, Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Division of Cardiology, Albert Einstein College of Medicine, Bronx, New York, USA.
Rodriguez D; Department of Medicine, Cardiac Arrhythmia Center, Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Division of Cardiology, Albert Einstein College of Medicine, Bronx, New York, USA.
Patel K; Department of Medicine, Cardiac Arrhythmia Center, Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Division of Cardiology, Albert Einstein College of Medicine, Bronx, New York, USA.
Polanco D; Department of Medicine, Cardiac Arrhythmia Center, Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Division of Cardiology, Albert Einstein College of Medicine, Bronx, New York, USA.
Trivedi C; St. David's Medical Center, Texas Cardiac Arrhythmia Institute, Austin, Texas, USA.
Mohanty S; St. David's Medical Center, Texas Cardiac Arrhythmia Institute, Austin, Texas, USA.
Della Rocca D; St. David's Medical Center, Texas Cardiac Arrhythmia Institute, Austin, Texas, USA.
Lakkireddy D; Kansas City Heart Rhythm Institute, HCA Midwest Health, Kansas City, Missouri, USA.
Natale A; St. David's Medical Center, Texas Cardiac Arrhythmia Institute, Austin, Texas, USA.
Di Biase L; Department of Medicine, Cardiac Arrhythmia Center, Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Division of Cardiology, Albert Einstein College of Medicine, Bronx, New York, USA.; Pokaż więcej
Źródło:: Journal of cardiovascular electrophysiology [J Cardiovasc Electrophysiol] 2022 Nov; Vol. 33 (11), pp. 2356-2366. Date of Electronic Publication: 2022 Aug 10.
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:: Atrial Fibrillation*/diagnosis
Atrial Fibrillation*/surgery
Catheter Ablation*/methods
Heart Failure*/diagnosis
Heart Failure*/therapy
Humans ; Male ; Middle Aged ; Aged ; Female ; Stroke Volume ; Anti-Arrhythmia Agents/adverse effects ; Ventricular Function, Left ; Treatment Outcome ; Randomized Controlled Trials as Topic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Artificial intelligence software standardizes electrogram-based ablation outcome for persistent atrial fibrillation.
Autorzy:: Seitz J; St. Joseph Hospital, Marseille, France.
Durdez TM; Volta Medical, Marseille, France.
Albenque JP; Clinique Pasteur, Toulouse, France.
Pisapia A; St. Joseph Hospital, Marseille, France.
Gitenay E; St. Joseph Hospital, Marseille, France.
Durand C; Infirmerie Protestante, Caluire-et-Cuire, France.
Monteau J; St. Joseph Hospital, Marseille, France.
Moubarak G; Clinique Ambroise Paré, Neuilly-sur-Seine, France.
Théodore G; University Hospital, Nice, France.
Lepillier A; Centre Cardiologique du Nord, Saint-Denis, France.
Zhao A; Clinique Ambroise Paré, Neuilly-sur-Seine, France.
Bremondy M; St. Joseph Hospital, Marseille, France.
Maluski A; St. Joseph Hospital, Marseille, France.
Cauchemez B; Clinique Ambroise Paré, Neuilly-sur-Seine, France.
Combes S; Clinique Pasteur, Toulouse, France.
Guyomar Y; Saint-Philibert Hospital, Lomme, France.
Heuls S; Saint-Philibert Hospital, Lomme, France.
Thomas O; Clinique Ambroise Paré, Neuilly-sur-Seine, France.
Penaranda G; Alphabio laboratory, Marseille, France.
Siame S; St. Joseph Hospital, Marseille, France.
Appetiti A; Volta Medical, Marseille, France.
Milpied P; Volta Medical, Marseille, France.
Bars C; St. Joseph Hospital, Marseille, France.
Kalifa J; Brown University, Providence, Rhode Island, USA.; Pokaż więcej
Źródło:: Journal of cardiovascular electrophysiology [J Cardiovasc Electrophysiol] 2022 Nov; Vol. 33 (11), pp. 2250-2260. Date of Electronic Publication: 2022 Sep 18.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Atrial Fibrillation*/diagnosis
Atrial Fibrillation*/surgery
Atrial Fibrillation*/drug therapy
Catheter Ablation*/adverse effects
Catheter Ablation*/methods
Pulmonary Veins*/surgery
Humans ; Prospective Studies ; Artificial Intelligence ; Treatment Outcome ; Anti-Arrhythmia Agents/therapeutic use ; Software ; Recurrence

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Promising Therapies for Atrial Fibrillation and Ventricular Tachycardia.
Autorzy:: Mircea AA; Victor Babes National Institute of Pathology, 050096 Bucharest, Romania.; Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Rusu M; Department for Cardiology, Angiology and Internal Intensive Care, Medical Faculty, RWTH Aachen University, 5207 Aachen, Germany.
Liehn EA; Victor Babes National Institute of Pathology, 050096 Bucharest, Romania.; Institute for Molecular Medicine, University of Southern Denmark, DK-5230 Odense, Denmark.
Bucur O; Victor Babes National Institute of Pathology, 050096 Bucharest, Romania.; Viron Molecular Medicine Institute, Boston, MA 02108, USA.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2022 Oct 20; Vol. 23 (20). Date of Electronic Publication: 2022 Oct 20.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Atrial Fibrillation*/drug therapy
Tachycardia, Ventricular*/drug therapy
Catheter Ablation*
Humans ; Electric Countershock ; Death, Sudden, Cardiac ; Anti-Arrhythmia Agents/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Efficacy of ablation index-guided pulmonary vein isolation in patients with paroxysmal atrial fibrillation.
Autorzy:: Jiang R; Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Chen M; The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Fan J; The First Peoples' Hospital of Yunnan Province, Yunnan, China.
Yi F; Xijing Hospital, Air Force Medical University, Xi'an, China.
Tang A; The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Liu X; Beijing Chaoyang Hospital affiliated to Capital Medical University, Beijing, China.
Zhu W; The Zhongshan Hospital, Fudan University, Shanghai, China.
Liu S; Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Huang X; Nanfang Hospital, Southern Medical University, Guangzhou, China.
Liu Q; Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Ju W; The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Zhang X; The First Peoples' Hospital of Yunnan Province, Yunnan, China.
Li J; Xijing Hospital, Air Force Medical University, Xi'an, China.
He J; The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Shi L; Beijing Chaoyang Hospital affiliated to Capital Medical University, Beijing, China.
Zhou G; Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Wang Y; Nanfang Hospital, Southern Medical University, Guangzhou, China.
Fu G; Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Jiang C; Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.; Pokaż więcej
Źródło:: Pacing and clinical electrophysiology : PACE [Pacing Clin Electrophysiol] 2022 Oct; Vol. 45 (10), pp. 1186-1193. Date of Electronic Publication: 2022 Sep 01.
Typ publikacji:: Randomized Controlled Trial; Journal Article
MeSH Terms:: Pulmonary Veins*/surgery
Atrial Fibrillation*/surgery
Catheter Ablation*
Radiofrequency Ablation*
Humans ; Anti-Arrhythmia Agents ; Treatment Outcome ; Recurrence

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Cost of cardiac stereotactic body radioablation therapy versus catheter ablation for treatment of ventricular tachycardia.
Autorzy:: Wei C; Department of Medicine, Stanford University School of Medicine, Palo Alto, California, USA.; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Boeck M; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Qian PC; Department of Cardiology, Westmead Hospital, Sydney, Australia.; Westmead Applied Research Centre, Faculty of Medicine and Health, University of Sydney, Westmead, Australia.
Vivenzio T; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Elizee Z; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Bredfeldt JS; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Kaplan RS; Harvard Business School, Boston, Massachusetts, USA.
Tedrow U; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Mak R; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Zei PC; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Pokaż więcej
Źródło:: Pacing and clinical electrophysiology : PACE [Pacing Clin Electrophysiol] 2022 Sep; Vol. 45 (9), pp. 1124-1131. Date of Electronic Publication: 2022 Jun 09.
Typ publikacji:: Journal Article
MeSH Terms:: Catheter Ablation*/methods
Radiosurgery*/methods
Tachycardia, Ventricular*
Anti-Arrhythmia Agents/therapeutic use ; Humans ; Retrospective Studies ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Hybrid ablation procedure for the treatment of nonparoxysmal atrial fibrillation: A systematic review and meta-analysis.
Autorzy:: Hao J; Department of Intensive Care Unit of Cardiovascular Surgery, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Xi Y; Department of Radiology, Guangzhou Women and Children's Medical Center, Guangzhou, China.
Chen W; Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Liang Y; Institute of Geriatric Medicine, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.
Lin Z; Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.; Institute of Geriatric Medicine, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.
Wei W; Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.; Pokaż więcej
Źródło:: Pacing and clinical electrophysiology : PACE [Pacing Clin Electrophysiol] 2022 Sep; Vol. 45 (9), pp. 1132-1140. Date of Electronic Publication: 2022 Jun 14.
Typ publikacji:: Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:: Atrial Fibrillation*
Catheter Ablation*/methods
Anti-Arrhythmia Agents/therapeutic use ; Anti-Bacterial Agents/therapeutic use ; Humans ; Prospective Studies ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Emergency catheter ablation: A feasible option for acute treatments of patients with unstable pre-excited atrial fibrillation.
Autorzy:: Chen W; Department of Cardiology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Xiao P; Department of Cardiology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Zhou G; Department of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.
Liu Z; Department of Cardiology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Chen S; Department of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.
Du H; Department of Cardiology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Li D; Department of Cardiology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Zhang C; Department of Cardiology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Xu Y; Department of Cardiology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Su L; Department of Cardiology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Liu S; Department of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.
Ling Z; Department of Cardiology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yin Y; Department of Cardiology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.; Pokaż więcej
Źródło:: Pacing and clinical electrophysiology : PACE [Pacing Clin Electrophysiol] 2022 Aug; Vol. 45 (8), pp. 975-983. Date of Electronic Publication: 2022 Apr 20.
Typ publikacji:: Journal Article
MeSH Terms:: Accessory Atrioventricular Bundle*/surgery
Atrial Fibrillation*/etiology
Atrial Fibrillation*/surgery
Catheter Ablation*/methods
Pre-Excitation Syndromes*/surgery
Wolff-Parkinson-White Syndrome*
Anti-Arrhythmia Agents ; Humans ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: A comparison of clinical outcomes and cost of radiofrequency catheter ablation for atrial fibrillation with monitored anesthesia care versus general anesthesia.
Autorzy:: Yokokawa M; Cardiac Arrhythmia Service, University of Michigan, Ann Arbor, Michigan, USA.
Chugh A; Cardiac Arrhythmia Service, University of Michigan, Ann Arbor, Michigan, USA.
Dubovoy A; Cardiac Anesthesiology, University of Michigan, Ann Arbor, Michigan, USA.
Engoren M; Cardiac Anesthesiology, University of Michigan, Ann Arbor, Michigan, USA.
Jongnarangsin K; Cardiac Arrhythmia Service, University of Michigan, Ann Arbor, Michigan, USA.
Latchamsetty R; Cardiac Arrhythmia Service, University of Michigan, Ann Arbor, Michigan, USA.
Ghanbari H; Cardiac Arrhythmia Service, University of Michigan, Ann Arbor, Michigan, USA.
Saeed M; Cardiac Arrhythmia Service, University of Michigan, Ann Arbor, Michigan, USA.
Cunnane R; Cardiac Arrhythmia Service, University of Michigan, Ann Arbor, Michigan, USA.
Crawford T; Cardiac Arrhythmia Service, University of Michigan, Ann Arbor, Michigan, USA.
Ghannam M; Cardiac Arrhythmia Service, University of Michigan, Ann Arbor, Michigan, USA.
Liang J; Cardiac Arrhythmia Service, University of Michigan, Ann Arbor, Michigan, USA.
Keast R; Cardiac Arrhythmia Service, University of Michigan, Ann Arbor, Michigan, USA.
Karpenko D; Cardiac Arrhythmia Service, University of Michigan, Ann Arbor, Michigan, USA.
Bogun F; Cardiac Arrhythmia Service, University of Michigan, Ann Arbor, Michigan, USA.
Pelosi F; Cardiac Arrhythmia Service, University of Michigan, Ann Arbor, Michigan, USA.
Dubovoy T; Cardiac Anesthesiology, University of Michigan, Ann Arbor, Michigan, USA.
Caldwell M; Cardiac Anesthesiology, University of Michigan, Ann Arbor, Michigan, USA.
Morady F; Cardiac Arrhythmia Service, University of Michigan, Ann Arbor, Michigan, USA.
Oral H; Cardiac Arrhythmia Service, University of Michigan, Ann Arbor, Michigan, USA.; Pokaż więcej
Źródło:: Journal of cardiovascular electrophysiology [J Cardiovasc Electrophysiol] 2022 Aug; Vol. 33 (8), pp. 1714-1722. Date of Electronic Publication: 2022 Jun 11.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Atrial Fibrillation*/diagnosis
Atrial Fibrillation*/epidemiology
Atrial Fibrillation*/surgery
Catheter Ablation*/adverse effects
Aged ; Anesthesia, General/adverse effects ; Anti-Arrhythmia Agents ; Humans ; Middle Aged ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Rhythm control without catheter ablation may have benefits beyond stroke prevention in rivaroxaban-treated non-permanent atrial fibrillation.
Autorzy:: Chiou WR; Division of Cardiology, Taitung MacKay Memorial Hospital, Taitung, Taiwan.; Department of Medicine, MacKay Medical College, New Taipei, Taiwan.
Lin PL; Division of Cardiology, Hsinchu MacKay Memorial Hospital, Hsinchu, Taiwan.; Department of Biological Science and Technology, National Yang Ming Chiao Tung University, Hsinchu, Taiwan.
Huang CC; Department of Healthcare Administration, I-Shou University, Kaohsiung, Taiwan.
Chuang JY; Department of Medical Education, MacKay Memorial Hospital, Taipei, Taiwan.
Liu LY; Department of Medicine, MacKay Medical College, New Taipei, Taiwan.; Division of Cardiology, Hsinchu MacKay Memorial Hospital, Hsinchu, Taiwan.
Su MI; Division of Cardiology, Taitung MacKay Memorial Hospital, Taitung, Taiwan.; Department of Medicine, MacKay Medical College, New Taipei, Taiwan.
Liao FC; Cardiovascular Center, MacKay Memorial Hospital, 92, Zhongshan North Road Section 2, Zhongshan District, Taipei, Taiwan.
Kuo JY; Department of Medicine, MacKay Medical College, New Taipei, Taiwan.; Cardiovascular Center, MacKay Memorial Hospital, 92, Zhongshan North Road Section 2, Zhongshan District, Taipei, Taiwan.
Tsai CT; Department of Medicine, MacKay Medical College, New Taipei, Taiwan.; Cardiovascular Center, MacKay Memorial Hospital, 92, Zhongshan North Road Section 2, Zhongshan District, Taipei, Taiwan.; Department of Artificial Intelligence and Medical Application, MacKay Junior College of Medicine, Nursing, and Management, Taipei, Taiwan.
Wu YJ; Department of Medicine, MacKay Medical College, New Taipei, Taiwan.; Department of Medical Education, MacKay Memorial Hospital, Taipei, Taiwan.; Cardiovascular Center, MacKay Memorial Hospital, 92, Zhongshan North Road Section 2, Zhongshan District, Taipei, Taiwan.
Wang KT; Division of Cardiology, Taitung MacKay Memorial Hospital, Taitung, Taiwan.; Department of Medicine, MacKay Medical College, New Taipei, Taiwan.
Lee YH; Department of Medicine, MacKay Medical College, New Taipei, Taiwan. .; Cardiovascular Center, MacKay Memorial Hospital, 92, Zhongshan North Road Section 2, Zhongshan District, Taipei, Taiwan. .; Department of Artificial Intelligence and Medical Application, MacKay Junior College of Medicine, Nursing, and Management, Taipei, Taiwan. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2022 Mar 08; Vol. 12 (1), pp. 3745. Date of Electronic Publication: 2022 Mar 08.
Typ publikacji:: Journal Article; Multicenter Study
MeSH Terms:: Atrial Fibrillation*/complications
Atrial Fibrillation*/drug therapy
Catheter Ablation*/adverse effects
Heart Failure*/drug therapy
Stroke*/epidemiology
Stroke*/etiology
Stroke*/prevention & control
Thromboembolism*/etiology
Anti-Arrhythmia Agents/adverse effects ; Humans ; Retrospective Studies ; Rivaroxaban/adverse effects ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Bayesian network meta-analysis comparing cryoablation, radiofrequency ablation, and antiarrhythmic drugs as initial therapies for atrial fibrillation.
Autorzy:: Elsayed M; Department of Cardiovascular Medicine, Cardiovascular Institute at Allegheny Health Network, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA.
Abdelfattah OM; Department of Internal Medicine, Morristown Medical Center, Atlantic Health System, Morristown, New Jersey, USA.
Sayed A; Department of Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Prasad RM; Department of Internal Medicine, Michigan State University, East Lansing, Michigan, USA.
Barakat AF; Division of Cardiovascular Disease, UPMC Heart and Vascular Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Elgendy IY; Department of Medicine, Weill Cornell Medicine-Qatar, Doha, Qatar.
Andrade J; Division of Cardiology, Montreal Heart Institute, Université de Montréal, Canada; University of British Columbia, Vancouver, British Columbia, Canada.
Jared Bunch T; Division of Cardiovascular Medicine, University of Utah, Salt Lake City, Utah, USA.
Thosani A; Division of Cardiac Electrophysiology, Department of Cardiology, Allegheny General Hospital, Allegheny Health Network, Pittsburgh, Pennsylvania, USA.
Saliba WI; Department of Cardiovascular Medicine, Section of Cardiac Pacing and Electrophysiology, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Wazni OM; Department of Cardiovascular Medicine, Section of Cardiac Pacing and Electrophysiology, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Hussein AA; Department of Cardiovascular Medicine, Section of Cardiac Pacing and Electrophysiology, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA.; Pokaż więcej
Źródło:: Journal of cardiovascular electrophysiology [J Cardiovasc Electrophysiol] 2022 Feb; Vol. 33 (2), pp. 197-208. Date of Electronic Publication: 2021 Dec 11.
Typ publikacji:: Journal Article; Meta-Analysis
MeSH Terms:: Atrial Fibrillation*/diagnosis
Atrial Fibrillation*/drug therapy
Atrial Fibrillation*/surgery
Catheter Ablation*/adverse effects
Catheter Ablation*/methods
Cryosurgery*/adverse effects
Radiofrequency Ablation*
Anti-Arrhythmia Agents/adverse effects ; Humans ; Network Meta-Analysis ; Recurrence ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Cost-effectiveness of catheter ablation versus medical therapy for the treatment of atrial fibrillation in the United Kingdom.
Autorzy:: Leung LWM; Department of Cardiology, St. George's University Hospitals NHS Foundation Trust, London, UK.
Imhoff RJ; Real-World Evidence and Late Phase Research, CTI Clinical Trial and Consulting Services, Covington, Kentucky, USA.
Marshall HJ; Department of Cardiology, Queen Elizabeth Hospital, Birmingham, UK.
Frame D; Real-World Evidence and Late Phase Research, CTI Clinical Trial and Consulting Services, Covington, Kentucky, USA.
Mallow PJ; Health Services Administration, Xavier University, Cincinnati, Ohio, USA.
Goldstein L; Franchise Health Economics and Market Access, Biosense Webster, Inc, Irvine, California, USA.
Wei T; Franchise Health Economics and Market Access, Biosense Webster, Inc, Irvine, California, USA.
Velleca M; Health Economics and Market Access, Johnson & Johnson Medical S.p.A, Pomezia, Italy.
Taylor H; Health Economics and Market Access, Johnson & Johnson Medical Limited, Berkshire, UK.
Gallagher MM; Department of Cardiology, St. George's University Hospitals NHS Foundation Trust, London, UK.; Pokaż więcej
Źródło:: Journal of cardiovascular electrophysiology [J Cardiovasc Electrophysiol] 2022 Feb; Vol. 33 (2), pp. 164-175. Date of Electronic Publication: 2021 Dec 16.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Atrial Fibrillation*/diagnosis
Atrial Fibrillation*/surgery
Catheter Ablation*/methods
Anti-Arrhythmia Agents/therapeutic use ; Cost-Benefit Analysis ; Humans ; Markov Chains ; State Medicine ; United Kingdom

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Anti-Arrhythmia Agents"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język